Format

Send to

Choose Destination
Acta Neuropathol. 2018 Nov;136(5):805-810. doi: 10.1007/s00401-018-1913-0. Epub 2018 Sep 26.

cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".

Author information

1
Department of Pathology, Robert H. Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Ward Building, 3-140, 303 E. Chicago Ave, Chicago, IL, 60611, USA. Daniel.brat@northwestern.edu.
2
Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
3
Department of Neurosurgery, Huntsman Cancer Center, University of Utah, Salt Lake City, UT, USA.
4
Department of Neurosurgery, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA.
5
Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
6
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
7
Department of Pathology, University of Colorado School of Medicine, Aurora, CO, USA.
8
Department of Pathology, University of California San Francisco, San Francisco, CA, USA.
9
Department of Neuropathology, Heinrich Heine University, Düsseldorf, Germany.
10
German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Düsseldorf, Germany.
11
Malnati Brain Tumor Institute, Robert H. Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
12
Department of Neuropathology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
13
Clinical Cooperation Unit Neuropathology, German Cancer Institute (DKFZ), Heidelberg, Germany.
14
Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.
PMID:
30259105
PMCID:
PMC6204285
[Available on 2019-11-01]
DOI:
10.1007/s00401-018-1913-0

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center